Skip to main content
. 2016 Mar 25:289–322. doi: 10.1016/B978-0-12-802029-6.00012-8

Table 12.2.

Recent funding amount breakdowns by type of threat for the Project BioShield program

Countermeasure area/product Funding amount Explanation
Anthrax $1,456,130,000 Antitoxins and vaccines
Botulism $476,000,000 Antitoxins
Smallpox $1,085,000,000 Vaccines
Radionuclear $234,500,000 Radiation sickness
Nerve agents $60,800,000 Midazolam for seizures

From Department of Health and Human Services Project BioShield Annual Report: January–December 2013.